Even as the patent on semaglutide expires, the market may have already moved toward these superior multi-receptor agents, effectively creating a new cycle of exclusivity
Its true that some people have genetic problems with GLP-1 production
Butler J, Abildstrm SZ, Borlaug BA, Davies MJ, Kitzman DW, Petrie MC, et al
The global market for GLP-1 receptor agonists was valued at USD 53.46 billion in 2024 and is expected to grow to USD 156.71 billion by 2030 , reflecting a compound annual growth rate of 17.46% between 2025 and 2030
Several miRNAs are involved in cell differentiation and mature cell functioning
Ros clinicians can order lab work when necessary and, when appropriate, may recommend patients seek in-person care, he said